Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are prioritized for R&D in public health emergency contexts.
Kinshasa, Democratic Republic of the Congo — Showing early symptoms of hemorrhagic fever, the patient sits quietly on her bed, wrangling two toddlers desperate to flee the cell-like hospital room in Ingende, a remote town in the Democratic Republic of the Congo (DRC).
